Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation.

Hahm, Eun-Ryeong; Kim, Su-Hyeong; Pore, Subrata K; Mathan, Sivapar V; Singh, Rana P; Singh, Shivendra V

Hahm, Eun-Ryeong; Kim, Su-Hyeong; Pore, Subrata K; Mathan, Sivapar V; Singh, Rana P; Singh, Shivendra V.

Afiliação

Hahm ER; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Kim SH; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Pore SK; Amity Institute of Molecular Medicine & Stem Cell Research, Amity University, Noida, India.
Mathan SV; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Singh RP; Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, New Delhi, India.
Singh SV; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Mol Carcinog ; 63(2): 301-313, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37921547

Assuntos

Neoplasias Ósseas; Neoplasias da Mama; Isotiocianatos; Humanos; Feminino; Ácido Zoledrônico/farmacologia; Ácido Zoledrônico/uso terapêutico; Neoplasias da Mama/genética; Linhagem Celular Tumoral; Osteoclastos/metabolismo; Osteoclastos/patologia; Transformação Celular Neoplásica; Neoplasias Ósseas/tratamento farmacológico

Palavras-chave

benzyl isothiocyanate; bone metastasis; osteoclast; zoledronic acid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Isotiocianatos Limite: Female / Humans Idioma: En Revista: Mol Carcinog Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google